Kim, Y. (2009) “Zanolimumab (Humax-CD4), a fully human monoclonal antibody with significant clinical responses in cutaneous T-cell lymphoma”, Hematology Meeting Reports (formerly Haematologica Reports), 3(1). doi: 10.4081/hmr.v3i1.540.